JAZZ
Jazz Pharmaceuticals PLC
235.70$
+1.1%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -243.3% | -127.9% | -124.2% | -192.9% | -12.4% | 33.9% | 55.7% | 42.6% | 32.5% | 34.6% | 40.2% | 39.7% | 42.8% | 42.2% | 35.9% | 38.1% | 25.2% | 34.8% | 28.5% | 34.3% | 31.8% | |
| 25.4% | 23.0% | 16.1% | 22.3% | 7.1% | 5.0% | 2.9% | 12.7% | 9.4% | 11.4% | 8.2% | 7.6% | 10.2% | 11.5% | 17.1% | 11.8% | 17.9% | 17.2% | 16.7% | 16.2% | 16.3% | |
| – | – | 9.3% | 12.0% | 4.6% | 4.7% | 7.6% | 3.9% | 5.1% | 5.9% | 6.9% | 6.6% | 6.6% | 5.4% | 5.1% | 5.1% | 6.1% | 6.1% | 5.9% | 6.1% | 6.8% | |
| – | – | – | – | – | – | 8.1% | -22.4% | 7.1% | 5.8% | 4.6% | 3.8% | -6.3% | 3.5% | -0.4% | 6.6% | 19.5% | 3.8% | – | – | – | |
| 13.3% | 34.3% | 42.1% | 3.1% | -18.8% | -3.3% | -1.3% | -0.9% | -9.3% | -4.4% | -0.5% | -1.5% | 1.7% | 1.2% | -6.9% | -3.6% | -1.5% | 0.3% | -5.3% | -1.9% | 0.4% | |
| 6.6% | 3.7% | 4.8% | 42.6% | 4.7% | 2.7% | 2.1% | 3.8% | 1.3% | 20.4% | 2.7% | 12.2% | 7.0% | 7.0% | 8.4% | 16.0% | 1.5% | 13.6% | 0.6% | 1.2% | 4.9% | |
| -717.1% | -3.4% | 8.2% | -17.7% | -4.8% | -1.2% | -29.8% | -67.5% | -1.3% | -91.0% | -0.2% | -117.6% | -16.6% | -20.9% | -7.2% | -42.6% | -168.4% | -12.2% | -4.3% | -12.5% | -35.4% | |
| – | – | – | 9.5% | – | – | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | – | 2.7% | 4.2% | 3.2% | 2.7% | – | – | – | |
| – | – | 150.8% | 9.5% | 5.0% | 35.9% | 6.0% | -4.3% | -15.6% | -3.6% | -4.6% | -18.7% | -6.1% | -27.7% | -13.9% | -6.2% | -1.2% | 0.0% | -7.0% | -7.7% | -2.9% | |
| – | – | – | – | – | – | -18.2% | 74.9% | 10.0% | 75.4% | -12.6% | 54.9% | -20.2% | -1.7% | -1.5% | 25.0% | 125.1% | -15.9% | -0.8% | 9.2% | -18.3% | |
| 899.4% | 261.3% | 152.8% | 95.0% | 9.9% | -15.8% | -12.2% | 76.5% | -2.8% | 60.8% | -16.2% | 36.4% | -25.3% | -25.3% | -13.6% | 22.3% | 128.3% | -14.5% | -8.0% | 0.5% | -20.5% | |
| -60.9% | 130.0% | 36.7% | -115.6% | -7.2% | 16.8% | 13.7% | 52.1% | 28.6% | 4.1% | 23.0% | -41.9% | 1.2% | -4.0% | 15.2% | 17.8% | -15.1% | 7.9% | 16.3% | 22.3% | -23.9% | |
| -249.9% | -131.6% | -129.0% | -235.5% | -17.1% | 31.2% | 53.6% | 38.8% | 31.2% | 14.2% | 37.4% | 27.5% | 35.8% | 35.3% | 27.5% | 22.0% | 23.7% | 21.1% | 27.9% | 33.1% | 26.9% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.